Our impressive growth has ranked us three times in the list of the UK’s fastest growing privately owned companies, the Fast Track 100. Four of our product have also won the international Red Dot Product Design Award in Germany.
Winning design is fantastic but most importantly our technologies must be both safe and effective. Since 2014, Professor Alun Davies, Professor of Vascular Surgery, and his team at Imperial College London have been undertaking clinical trials with Revitive Circulation Booster® in patients with Peripheral Arterial Disease, Chronic Venous Insufficiency and Diabetes.
For our breathing technology, AeroSure, Professor Sally Singh, Professor of Pulmonary & Cardiac Rehabilitation at University Hospitals of Leicester NHS Trust, has led our clinical trials in Chronic Obstructive Pulmonary Disease (COPD) since 2016.
Professor Sally Singh is also Principal Investigator assessing the benefits of Revitive Knee in patients with Osteoarthritis since 2019.
University of Hertfordshire are undertaking further clinical trials to assess the improvements in people over the age of 65 with leg health symptoms using Revitive.